These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CLINICAL TRIALS OF HYDROXYUREA IN PATIENTS WITH CANCER AND LEUKEMIA. FISHBEIN WN; CARBONE PP; FREIREICH EJ; MISRA D; FREI E Clin Pharmacol Ther; 1964; 5():574-80. PubMed ID: 14209774 [No Abstract] [Full Text] [Related]
3. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA. SHULLENBERGER CC Cancer Chemother Rep; 1964 Aug; 40():49-50. PubMed ID: 14206918 [No Abstract] [Full Text] [Related]
4. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION. KRAKOFF IH; SAVEL H; MURPHY ML Cancer Chemother Rep; 1964 Aug; 40():53-5. PubMed ID: 14206920 [No Abstract] [Full Text] [Related]
5. [CLINICAL KIDNEY FINDINGS IN LEUKEMIA AND THEIR CORRELATION WITH AUTOPSY RESULTS]. HELBIG W; VOIGT KG Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():163-84. PubMed ID: 14165086 [No Abstract] [Full Text] [Related]
6. [CHROMATOGRAPHIC STUDY OF THE FREE AMINO ACIDS IN THE BLOOD IN CHRONIC MYELOID LEUKEMIA]. RONCHI F; GUACCI L; DEPASQUALE C Prog Med (Napoli); 1963 Aug; 19():484-7. PubMed ID: 14125617 [No Abstract] [Full Text] [Related]
7. UREASE CATALYSIS. II. INHIBITION OF THE ENZYME BY HYDROXYUREA, HYDROXYLAMINE, AND ACETOHYDROXAMIC ACID. FISHBEIN WN; CARBONE PP J Biol Chem; 1965 Jun; 240():2407-14. PubMed ID: 14304845 [No Abstract] [Full Text] [Related]
8. STUDIES OF URIC ACID BIOSYNTHESIS IN CHRONIC LEUKEMIA. KRAKOFF IH; BLIS ME Acta Unio Int Contra Cancrum; 1964; 20():1105-8. PubMed ID: 14274708 [No Abstract] [Full Text] [Related]
12. [THE BLOOD TRYPTOPHAN CONTENT IN CHILDREN WITH DISEASES OF THE BLOOD SYSTEM]. GRADOVA MG; SHOKINA NI Vopr Okhr Materin Det; 1963 Oct; 8():24-9. PubMed ID: 14123217 [No Abstract] [Full Text] [Related]
13. Clinical trial of hydroxyurea in chronic myelocytic leukemia. Baudo F; Cattaneo N; Cipriani D; De Cataldo F; Pensabene A; Tiso R Haematol Lat; 1967; 10(4):359-62. PubMed ID: 5243231 [No Abstract] [Full Text] [Related]
15. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439 [TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of chronic myelocytic leukemia. Status of the German Multicenter Study on busulfan versus hydroxyurea versus alpha interferon, October 1897]. Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H Onkologie; 1988 Feb; 11(1):25-9. PubMed ID: 3283622 [TBL] [Abstract][Full Text] [Related]
17. Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. Kennedy BJ; Yarbro JW JAMA; 1966 Mar; 195(12):1038-43. PubMed ID: 5218042 [No Abstract] [Full Text] [Related]
18. Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment. Friedrich S; Raff K; Landthaler M; Karrer S Eur J Dermatol; 2004; 14(5):343-6. PubMed ID: 15358575 [TBL] [Abstract][Full Text] [Related]
19. Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Payne AN; Jackson WP; Salmon JA; Nicholls A; Yeadon M; Garland LG Agents Actions Suppl; 1991; 34():189-99. PubMed ID: 1793063 [TBL] [Abstract][Full Text] [Related]
20. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. Koller CA; Miller DM N Engl J Med; 1986 Dec; 315(23):1433-8. PubMed ID: 2431313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]